Skin patch approved for treatment of overactive bladder.
D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage*; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D014555:Urination Disorders / Q000188:drug therapy*
D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin